AMCP submits comments to Maryland House leadership expressing concerns with specific provisions of House Bill 1273 regarding the regulation of biological products and the substitution of interchangeable biological products when dispensed by pharmacists.
AMCP submits comments to Maryland House leadership expressing concerns with specific provisions of House Bill 1273 regarding the regulation of biological products and the substitution of interchangeable biological products when dispensed by pharmacists.